A randomized parallel-group trial of propofol versus midazolam for sadation during ERCP
Not Applicable
- Conditions
- Biliopancreatic disorder
- Registration Number
- JPRN-UMIN000007732
- Lead Sponsor
- Hiroshima University hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients who are deemed inappropriate to sedation because of bad general ccondition 2. Patients with severe cardiovascular or respiratory disorder 3. Patients who have decompensated liver cirrhosis 4. Patients who have experienced a serious adverse effect by propofol or midazolam 5. Patient with known contraindications for propofol or midazolam 6. Pregnant or potentially pregnant women 7. Other patients who are in the opinion of the caring investigator unfit for enrollment in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method